Cargando…

Comparison of medication adherence between type 2 diabetes mellitus patients who pay for their medications and those who receive it free: a rural Asian experience

BACKGROUND: Treatment plans fail if patients have poor medication adherence. Our aim was to compare medication adherence, reasons for non-adherence, and satisfaction with community support among type 2 diabetes mellitus patients who pay for their medications and those who receive it free. METHODS: A...

Descripción completa

Detalles Bibliográficos
Autores principales: Rathish, Devarajan, Hemachandra, Ruvini, Premadasa, Thilini, Ramanayake, Sasini, Rasangika, Chathuri, Roshiban, Ravi, Jayasumana, Channa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6346564/
https://www.ncbi.nlm.nih.gov/pubmed/30678724
http://dx.doi.org/10.1186/s41043-019-0161-9
_version_ 1783389778965692416
author Rathish, Devarajan
Hemachandra, Ruvini
Premadasa, Thilini
Ramanayake, Sasini
Rasangika, Chathuri
Roshiban, Ravi
Jayasumana, Channa
author_facet Rathish, Devarajan
Hemachandra, Ruvini
Premadasa, Thilini
Ramanayake, Sasini
Rasangika, Chathuri
Roshiban, Ravi
Jayasumana, Channa
author_sort Rathish, Devarajan
collection PubMed
description BACKGROUND: Treatment plans fail if patients have poor medication adherence. Our aim was to compare medication adherence, reasons for non-adherence, and satisfaction with community support among type 2 diabetes mellitus patients who pay for their medications and those who receive it free. METHODS: A descriptive cross-sectional study was conducted at Anuradhapura, Sri Lanka, among patients who were on oral anti-diabetic drugs for at least 3 months. They were grouped into two: universal-free group and fee-paying group. Three different scales were used to score medication adherence, reasons for non-adherence, and satisfaction with community support. Fisher’s exact test was performed to determine if there was a significant difference between the two groups (p < 0.05) concerning medication adherence and satisfaction with community support. RESULTS: The median (IQR) medication adherence scores for fee-paying group and universal-free group were 3 (2-3) and 3 (3-3), respectively; the median (IQR) scores for satisfaction with community support were 5 (2–6) and 4 (4–6), respectively. Both the adherence and the satisfaction failed to show a significant difference between the two groups. Forgetfulness, being away from home, complex drug regime, and willingness to avoid side effects were common reasons of non-adherence for both the groups. CONCLUSIONS: There was no significant difference in medication adherence between the universal-free group and fee-paying group, despite of having a significantly different income. The universal-free health service would be a probable reason. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s41043-019-0161-9) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6346564
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-63465642019-01-30 Comparison of medication adherence between type 2 diabetes mellitus patients who pay for their medications and those who receive it free: a rural Asian experience Rathish, Devarajan Hemachandra, Ruvini Premadasa, Thilini Ramanayake, Sasini Rasangika, Chathuri Roshiban, Ravi Jayasumana, Channa J Health Popul Nutr Research Article BACKGROUND: Treatment plans fail if patients have poor medication adherence. Our aim was to compare medication adherence, reasons for non-adherence, and satisfaction with community support among type 2 diabetes mellitus patients who pay for their medications and those who receive it free. METHODS: A descriptive cross-sectional study was conducted at Anuradhapura, Sri Lanka, among patients who were on oral anti-diabetic drugs for at least 3 months. They were grouped into two: universal-free group and fee-paying group. Three different scales were used to score medication adherence, reasons for non-adherence, and satisfaction with community support. Fisher’s exact test was performed to determine if there was a significant difference between the two groups (p < 0.05) concerning medication adherence and satisfaction with community support. RESULTS: The median (IQR) medication adherence scores for fee-paying group and universal-free group were 3 (2-3) and 3 (3-3), respectively; the median (IQR) scores for satisfaction with community support were 5 (2–6) and 4 (4–6), respectively. Both the adherence and the satisfaction failed to show a significant difference between the two groups. Forgetfulness, being away from home, complex drug regime, and willingness to avoid side effects were common reasons of non-adherence for both the groups. CONCLUSIONS: There was no significant difference in medication adherence between the universal-free group and fee-paying group, despite of having a significantly different income. The universal-free health service would be a probable reason. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s41043-019-0161-9) contains supplementary material, which is available to authorized users. BioMed Central 2019-01-24 /pmc/articles/PMC6346564/ /pubmed/30678724 http://dx.doi.org/10.1186/s41043-019-0161-9 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Rathish, Devarajan
Hemachandra, Ruvini
Premadasa, Thilini
Ramanayake, Sasini
Rasangika, Chathuri
Roshiban, Ravi
Jayasumana, Channa
Comparison of medication adherence between type 2 diabetes mellitus patients who pay for their medications and those who receive it free: a rural Asian experience
title Comparison of medication adherence between type 2 diabetes mellitus patients who pay for their medications and those who receive it free: a rural Asian experience
title_full Comparison of medication adherence between type 2 diabetes mellitus patients who pay for their medications and those who receive it free: a rural Asian experience
title_fullStr Comparison of medication adherence between type 2 diabetes mellitus patients who pay for their medications and those who receive it free: a rural Asian experience
title_full_unstemmed Comparison of medication adherence between type 2 diabetes mellitus patients who pay for their medications and those who receive it free: a rural Asian experience
title_short Comparison of medication adherence between type 2 diabetes mellitus patients who pay for their medications and those who receive it free: a rural Asian experience
title_sort comparison of medication adherence between type 2 diabetes mellitus patients who pay for their medications and those who receive it free: a rural asian experience
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6346564/
https://www.ncbi.nlm.nih.gov/pubmed/30678724
http://dx.doi.org/10.1186/s41043-019-0161-9
work_keys_str_mv AT rathishdevarajan comparisonofmedicationadherencebetweentype2diabetesmellituspatientswhopayfortheirmedicationsandthosewhoreceiveitfreearuralasianexperience
AT hemachandraruvini comparisonofmedicationadherencebetweentype2diabetesmellituspatientswhopayfortheirmedicationsandthosewhoreceiveitfreearuralasianexperience
AT premadasathilini comparisonofmedicationadherencebetweentype2diabetesmellituspatientswhopayfortheirmedicationsandthosewhoreceiveitfreearuralasianexperience
AT ramanayakesasini comparisonofmedicationadherencebetweentype2diabetesmellituspatientswhopayfortheirmedicationsandthosewhoreceiveitfreearuralasianexperience
AT rasangikachathuri comparisonofmedicationadherencebetweentype2diabetesmellituspatientswhopayfortheirmedicationsandthosewhoreceiveitfreearuralasianexperience
AT roshibanravi comparisonofmedicationadherencebetweentype2diabetesmellituspatientswhopayfortheirmedicationsandthosewhoreceiveitfreearuralasianexperience
AT jayasumanachanna comparisonofmedicationadherencebetweentype2diabetesmellituspatientswhopayfortheirmedicationsandthosewhoreceiveitfreearuralasianexperience